Current studies have consistently shown that people taking the newest GLP medications can expect to lose around 15% to 20% of their body weight over the course of 68 weeks
The peptide landscape, in terms of legality, is constantly evolving, so its possible that Selank will one day become more widely available outside of Russia
Clinical trial delays could also shorten any periods during which we may have the exclusive right to commercialize our product candidates, if approved, or allow our competitors to bring comparable products to market before we do, which could impair our ability to successfully commercialize our product candidates and may harm our business, financial condition, results of operations and prospects
It also makes the data harder to translate into simple clinical endpoints, which is a tension that runs through the entire GHK-Cu literature
It may be a better fit for: Because bariatric surgery permanently changes digestion and eating patterns, long-term commitment to nutrition, supplementation, hydration, and structured routines becomes especially important
